Dingdang Medicine Express, a Chinese online drug retail platform, has secured a RMB600 million (US$89.13 million) series B round of financing, according to a statement released on Thursday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?